Vytrus Biotech (private company)

See something wrong or missing? Let us know
Offices:
Barcelona
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Vytrus Biotech was foundedx as Phyture Biotech, a spin-off company of the Faculty of Pharmacy at the Universitat de Barcelona, from a research group with more than 40 years of experience in the technology of plant cell cultures. On 2011 we launched the company's first cosmetic ingredient, and in 2013, the first medical device, based in the plant cell cultures technology, and pioneer in the Spanish market.

Companies with similar profile to Vytrus Biotech:

CompanyCriteria
Sweden Scandinavian Real Hearts
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Sigrid Therapeutics
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Algenex
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain ARTHEx Biotech S.L.
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Pulmobiotics S.L
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Biograil
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncoheroes Biosciences
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Finland Sooma Medical
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Cirqle Biomedical
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain ViveBiotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway SonoClear
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway APIM Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark AFYX Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland DelSiTech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Spain Sanifit Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark InProTher
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Tenboron
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes